Confirmed Speakers

Prof. Olivier Verscheure

Prof. Olivier Verscheure

Executive Director of the Swiss Data Science Center

In parallel with his responsibilities as a titular professor at the Ecole Polytechnique Fédérale de Lausanne (EPFL), Olivier Verscheure is the director and founder of the Swiss Data Science Center (SDSC). Olivier Verscheure also co-leads a joint training program between EPFL and HEC Lausanne, specifically designed for senior executives. Since 2018, he has been a member of the Board of Directors of Lonza, a global leader in the life sciences sector that provides products and services to the pharmaceutical, biotechnology, and specialized healthcare industries.

Olivier Verscheure began his career at IBM Research after earning his Ph.D. in computer science from EPFL. He held several research and leadership positions at the IBM T. J. Watson Research Center in New York and co-created and co-directed the IBM Research center in Dublin, Ireland, before joining EPFL in 2016.

Prof. Martin Vetterli

Prof. Martin Vetterli

President of EPFL

Martin Vetterli, a researcher and teacher, has served as the president of École Polytechnique Fédérale de Lausanne (EPFL) since 2017. He is also a full professor at EPFL’s AudioVisual Communications Laboratory and an expert in the Swiss education and research landscape. He completed an electrical engineering degree at ETH Zurich in 1981, a Master’s degree at Stanford University in 1982, and his PhD at EPFL in 1986.

His next stop was Columbia University, where he taught as an assistant and then associate professor. He was appointed as a full professor at the University of California, Berkeley, in the Department of Electrical Engineering and Computer Science.

Two years later, at the request of EPFL President Jean-Claude Badoux, Prof. Vetterli returned to EPFL as a full professor. He was put in charge of the AudioVisual Communications Laboratory, a position he still holds today. He served as EPFL’s vice president of international relations and then of institutional affairs from 2004 to 2011, and as dean of the School of Computer and Communication Sciences in 2011 and 2012. He also taught at ETH Zurich and Stanford University. From 2013 to 2016, Prof. Vetterli was the president of the National Research Council of the Swiss National Science Foundation (SNSF)

In his research, Prof. Vetterli focuses on electrical engineering, computer cience and applied mathematics. His particular areas of interest are wavelet theory, image and video compression, and self-organized communication systems. His work has earned him numerous national and international awards, including the Swiss National Latsis Prize in 1996. He received honorary doctorate degrees in 2021 from the KTH Royal Institute of Technology in Stockholm and from the University of Bordeaux. Prof. Vetterli has published more than 200 journal articles and is a co-author of three reference works. He is also behind some fifty patents, which have led to several startups being spin-off from his laboratory, such as Dartfish, Illusonic and Artmyn, and to technology transfers through patent sales, for instance to Qualcomm and Rambus.

Prof. Susan Gasser

Prof. Susan Gasser

Director of ISREC and Member of the ETH Board

Prof. Susan M. Gasser completed her BA at the University of Chicago, and her PhD at the University of Basel in Biochemistry. She studied chromatin and chromosome organization in budding yeast, combining genetics, microscopy and biochemical approaches at the Swiss Institute for Experimental Cancer Research (ISREC) in Lausanne and as professor of Molecular Biology at the University of Geneva from 1986 – 2004. 

From 2004 to 2019, she was the Director of the Friedrich Miescher Institute for Biomedical Research, where she also led a research group in epigenetics until the end of 2020, expanding her research into C. elegans and human cells. 

Since 2021, Susan Gasser is guest professor at the University of Lausanne and is Director of the ISREC Foundation, supporting the Agora institute and translational cancer research. Susan Gasser studied the functional impact of the spatial packaging of chromatin in the interphase nucleus and with respect to genome stability and epigenetic regulation, optimizing live imaging techniques in the analysis of chromatin dynamics with time-lapse fluorescence imaging. 

She was elected to the Académie de France, EMBO, AAAS, US Academy of Sciences and the Swiss Academy of Medical Sciences, and has received various awards and honorary doctorates for her research.  

She serves on the ETH Board, the Swiss Science Council and the Board of Directors of UCB SA, in Brussels, and has been a strong supporter of women in science in Switzerland and beyond.

Prof. Andreas Wicki

Prof. Andreas Wicki

University Hospital of Zurich - Vice-Chairman of the Department of Medical Oncology and Hematology and Director of the Comprehensive Cancer Center, Zurich


Andreas Wicki is a Swiss oncologist known for his contributions to cancer research and clinical practice. His academic journey began at the University of Basel, where he completed his medical education and subsequently earned his Ph.D. with top honors in cell biology. His doctoral research, conducted in the Laboratory of Tumor Biology at the Institute of Biochemistry and Genetics, was supported by fellowships from the Swiss Academy of Medical Sciences and the Swiss National Science Foundation.

Andreas Wicki served as a resident in internal medicine at the District Hospital in Rheinfelden under the mentorship of Dr. H.U. Iselin before transitioning to a residency at the University Hospital Basel. During his residency, Andreas Wicki gained experience in internal medicine, including rotations in the emergency department and intensive care unit, as well as oncology under the guidance of Prof. R. Herrmann. He then switched to the University Hospital Freiburg im Breisgau, where he was a clinical fellow in the allogeneic transplant unit. Upon his return to the University Hospital Basel, he held positions as a consultant and head of the Phase 1 Oncology Unit, where he led clinical trials and contributed to the field of personalized cancer therapy. His research qualifications include extensive experience in clinical research, particularly in the design and implementation of innovative oncology trials in the field of precision oncology.

Andreas Wicki currently serves as a Professor of Oncology at the University of Zurich, Vice Chairman of the Department of Oncology & Hematology at the University Hospital Zurich and Director of the Comprehensive Cancer Center Zurich (CCCZ), Clinical Program.

Dr. Daniel Stekhoven

Dr. Daniel Stekhoven

ETH Zurich, Director of Nexus Personalized Health Technologies


Daniel Stekhoven is the director of the core facility NEXUS Personalized Health Technologies at ETH Zurich. NEXUS offers tailor-made services for biomedical research and development projects. In addition, they build and maintain robust solutions for sensitive and high-value health data and activities. Dan is also senior scientist at ETH Zurich. His research interests are in computational reproducibility, FAIR data, and clinical bioinformatics.

He is also a member of the steering committee in the Swiss Reproducibility Network and a member of the National ORD Task Force Health & Life Sciences. Dan obtained a Ph.D. in Mathematics at ETH Zurich.

 

Prof. Catherine Jutzeler

Prof. Catherine Jutzeler

Assistant Professor of Biomedical Data Science, ETH Zurich

Catherine Jutzeler is an Assistant Professor of Biomedical Data Science at the ETH Zurich. After completing her BSc and MSc in pharmaceutical science, she pursued her doctoral studies jointly at ETH Zurich and the University Clinic Balgrist applying neurophysiological and neuroimaging methods to assess the neural plasticity in patients recovering from spinal cord injury. Catherine conducted her postdoctoral studies in the field of neuro-pharmacoepidemiology and data science at the University of British Columbia in Vancouver, Canada. Since January 2022, Catherine and her research group are part of the ETH Department of Health Science and Technology. Her research group focuses on identifying the underlying causes, risk factors, and biomarkers associated with disease progression. Central to their investigations are a blend of prospective and retrospective studies that merge genetic, biochemical, and clinical assessments, as well as medication history. They employ a multidisciplinary approach, combining traditional epidemiological methods with advanced machine-learning algorithms. Currently, the team is actively engaged in several research endeavors spanning spinal cord injury, pediatric oncology, lower back pain, and infectious diseases such as sepsis in both pediatric and adult populations.
Since August 2022, Catherine has been co-leading the National Data Stream (NDS) project titled “Personalized, Data-Driven Prediction and Assessment of Infection-Related Outcomes in Swiss ICUs (IICU)” alongside Professor Adrian Egli. This collaborative initiative involves 22 laboratories and academic groups as well as 5 university hospitals of across Switzerland. The IICU national data stream is poised to become an unparalleled resource in the country, offering comprehensive insights into sepsis and its underlying mechanisms.

Dr. Noushin Hadadi

Dr. Noushin Hadadi

Director of Data Science and Bioinformatics, Novigenix

Noushin Hadadi trained as a Systems Biologist, specializing in computational exploration of biological networks through the integration of multi-omics data. She earned her Ph.D. from the Swiss Federal Institute of Technology (EPFL), focused on the modeling of complex systems. Passionate about utilizing data-driven insights to drive impactful healthcare solutions, Noushin held the position of Director of Data Science and Bioinformatics at Novigenix SA in Lausanne, Switzerland. There, she led teams in the development of diagnostic biomarkers and drug target discovery pipelines for precision oncology applications.

Previously, she conducted postdoctoral research at the University of Geneva and the University of Lausanne, focusing on biomedical data engineering, microbiome analysis, and AI applications in omics data analysis. Her work spans both academia and industry, where she employs computational methods to understand the intricacies of biology.

Antoine Maison

Antoine Maison

Head of Digital Innovation, Tigen Pharma

Antoine Maison is the head of digital innovation at Tigen Pharma, a biotech company in the field of cell & gene therapies based in Lausanne. With over 10 years of experience in the field of data, Antoine Maison has been driving digital transformation and innovation projects in the pharmaceutical industry. With a data science education and background Antoine Maison is leveraging data-driven strategies to optimize business processes and accelerate research and development.

Prof. Jean-Philippe Vert

Prof. Jean-Philippe Vert

Chief R&D Officer at Owkin and PSL University Affiliate Research Professor at the Center for Computational Biology of Mines Paris

Jean-Philippe Vert is Chief R&D Officer at Owkin, an AI Biotech company that uses AI to discover and develop treatments for unmet medical needs, CEO at Bioptimus, a start-up building AI foundation models in biology, and professor (on leave) at PSL University Mines Paris. Before joining Owkin in 2022, he was a research scientist at Google Brain (2018-2022), where he led a research team working on core machine learning and computational biology; a research professor at ENS Paris’ mathematics Department (2016-2018); a Fullbright and Miller visiting professor at UC Berkeley’s Department of Statistics (2015-2016); a research team leader at the Curie Institute’s research center (2008-2018); a research professor and founding director of Mines ParisTech’s Centre for Computational Biology (2002-2018); and a research associate at Kyoto University’s Bioinformatics Center (2001-2002). He graduated in applied mathematics from Ecole Polytechnique (1995) and received his PhD in mathematics from Paris University (2001). His research interest concerns the theory and practice of statistical machine learning and artificial intelligence to model complex, high-dimensional and structured data, and their applications in computational biology and medicine.

Dr. Nora Toussaint

Dr. Nora Toussaint

Head of Biomedical Data Science at the Swiss Data Science Center

Nora Toussaint currently serves as the Head of Biomedical Data Science at the Swiss Data Science Center (SDSC) and at the ETH core facility NEXUS Personalized Health Technologies. She earned her PhD from the University of Tübingen, where she focused on the in silico design of peptide-based vaccines using combinatorial optimization and machine learning. During her postdoc at Memorial Sloan Kettering Cancer Center in New York and later as a staff scientist at the New York Genome Center, she worked on metagenomics, infectious diseases, and cancer. In 2015, Nora joined NEXUS Personalized Health Technologies at ETH Zurich where her focus shifted towards the management of clinical and biomedical research data. She has been instrumental in major national projects, such as the Tumor Profiler Project and the National Data Streams on Swiss Personalized Oncology (SPO-NDS) and Infections in Intensive Care Units (IICU-NDS). In May 2024, she assumed her current role at SDSC.

Nora is committed to open and reproducible biomedical research to enhance patient care and improve treatment outcomes.

Dr. Silvia Quarteroni

Dr. Silvia Quarteroni

Head of the Innovation Unit at the Swiss Data Science Center

Silvia Quarteroni is the Head of Innovation unit at the Swiss Data Science Center, leading a team of 25 scientists collaborating with Swiss companies and not-for-profit organisations to adopt data-driven solutions and integrate data science in their decision-making process.

Silvia is also an Innosuisse Innovation Council member for the ICT domain, promoting novelty and value creation in the Swiss economic landscape.

With a MSc in Computer Science from EPFL and a PhD in Computer Science from the University of York (UK), she has a research background in natural language processing at the Universities of York (UK) and Trento (Italy) as well as Politecnico Milan (Italy). In her academic career, she has focused on question-answering systems, human-computer dialgue and more generally on machine learning applied to text and audio. During the last 10 years, Silvia worked with several organizations as a technical lead, project manager and strategic partner in data science.

Dr. Kevin Vervier

Dr. Kevin Vervier

Sr. Data Scientist, Novartis

Kevin Vervier holds a PhD in Bioinformatics from Mines ParisTech, and an MSc in Statistics, Informatics and Modeling from the Université Claude Bernard Lyon1. He has 10 years of experience working in bioinformatics, statistics, and machine learning roles with applications to biomarker discovery. He joined the Multi-modal Data and Analytics Team at Novartis in 2022 focusing on oncology and immunology. Prior to this, Kevin supported the development of Microbiotica live bacterial therapeutics with applications in immuno-oncology and inflammatory bowel diseases (2020-2022); explored the richness and diversity of the human gut microbiome at the Wellcome Trust Sanger Institute (2018-2020); developed bioinformatics methods leveraging multi-omics data to enrich genome annotation at the Department of Psychiatry in the University of Iowa (2015-2018); improved structured machine learning algorithms by integrating domain knowledge in microbiology at BioMerieux (2011-2015). He is passionate about improving the interpretability of machine learning models and connecting them to biological knowledge, as well as best practices for clinical applications.